Dr Reddy's to market Biocodex products in Romania

Published On 2015-11-05 03:41 GMT   |   Update On 2021-08-10 08:45 GMT

Drug major Dr Reddy's Laboratories today said it has signed a pact with Biocodex to market the French-based firm's products in Romania.The company has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian market, Dr Reddy's Laboratories said in a statement."Biocodex has announced the change in partnership and effective October 1, 2015,...

Login or Register to read the full article
Drug major Dr Reddy's Laboratories today said it has signed a pact with Biocodex to market the French-based firm's products in Romania.

The company has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian market, Dr Reddy's Laboratories said in a statement.

"Biocodex has announced the change in partnership and effective October 1, 2015, Dr Reddy's has been given the complete rights for promotion and distribution of the Biocodex products across Romania," it added.

Earlier, Akacia was in partnership with Biocodex for similar distribution pact.

Dr Reddy's will aim to develop the access of the Romanian patients to the Biocodex's product portfolio including its well-known over the counter products Enterol and Otipax, the company said.

Shares of Dr Reddy's were trading at Rs 4,355.00 apiece, up 0.68 per cent on BSE in afternoon trade.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News